Today: 10 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Edgewise Therapeutics (EWTX) Stock News, Forecasts and Analysis: What’s Driving the December 2025 Move and What Comes Next

Edgewise Therapeutics (EWTX) Stock News, Forecasts and Analysis: What’s Driving the December 2025 Move and What Comes Next

Edgewise Therapeutics shares surged 20.8% to $25.55 on December 19, 2025, trading over 3.1 million shares after a prior decline. No new company press releases or major updates were issued in the past 24–48 hours. The move followed routine equity grant news on December 2 and Q3 results on November 6. Analyst price targets remain above current levels.
21 December 2025
··
CoreWeave Stock (CRWV) News, Forecasts and Analysis for Dec. 20, 2025: Citi’s Buy Call Fuels a Rally, but 2026 Execution Is the Real Test

CoreWeave Stock (CRWV) News, Forecasts and Analysis for Dec. 20, 2025: Citi’s Buy Call Fuels a Rally, but 2026 Execution Is the Real Test

CoreWeave shares jumped 22.6% to close at $83.00 on Dec. 19, 2025, after Citigroup renewed coverage with a Buy rating and a $135 price target. Trading volume topped 70 million shares. The move followed weeks of concern over data-center delays and debt. Q3 revenue reached $1.36 billion, up 134% year-over-year, but the company remains unprofitable with high interest costs.
21 December 2025
·
Trump Media & Technology Group (DJT) Stock: Latest News, Forecasts and Outlook After the $6 Billion TAE Fusion Deal (Dec. 20, 2025)

Trump Media & Technology Group (DJT) Stock: Latest News, Forecasts and Outlook After the $6 Billion TAE Fusion Deal (Dec. 20, 2025)

Trump Media & Technology Group announced a $6 billion all-stock merger with nuclear fusion firm TAE Technologies, with both companies’ shareholders expected to split ownership evenly. DJT shares surged over 30% on the news, closing Friday, Dec. 19 at $16.09, up 8.28%. The deal is set to close in mid-2026, pending approvals. Devin Nunes and Michl Binderbauer will serve as co-CEOs.
21 December 2025
··
Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings shares jumped 18.21% to $9.22 on Friday, Dec. 19, following a series of defense and autonomy updates and the completion of its $81.7 million Roboteam acquisition. The company also announced a new COO and a successful AI demining pilot in Israel. Analyst coverage over the weekend highlighted ONDS as a high-volatility momentum stock.
21 December 2025
·
Rivian Stock (RIVN) Surges Into Dec. 20, 2025: Latest News, Analyst Forecasts, and What Could Drive 2026

Rivian Stock (RIVN) Surges Into Dec. 20, 2025: Latest News, Analyst Forecasts, and What Could Drive 2026

Rivian shares closed near $22.45 on Dec. 20 after heavy trading and a series of autonomy-related headlines. The company announced board member Rose Marcario will step down Jan. 1, 2026, reducing the board to seven. Wedbush raised its price target to $25, citing Rivian’s AI and software push. Rivian also unveiled a custom autonomy chip made with TSMC and launched a new driver-assistance package.
21 December 2025
··
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

BioMarin Pharmaceutical will acquire Amicus Therapeutics in an all-cash deal valued at $4.8 billion, offering $14.50 per share. Amicus stock surged about 30% after the Dec. 19 announcement, trading near $14.18 as of Dec. 20. The deal awaits regulatory and shareholder approval, with closing expected in Q2 2026. Trading volume spiked as investors focused on merger risk and timing.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s $30-per-share all-cash tender offer, citing financing concerns and a potential $4.3 billion cost if the Netflix deal is abandoned. WBD stock closed at $27.77 on Dec. 19, near Netflix’s $27.75 per-share offer. Netflix reaffirmed its commitment to its $72 billion deal. Paramount continues to push its cash bid.
21 December 2025
···
BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai shares surged to $6.26 on Dec. 19, with trading volume topping 218 million after announcing a partnership with radar firm C Speed to deploy its ConductorOS AI platform for real-time threat detection. The company is also in focus over a $250 million Ask Sage acquisition deal and an upcoming share-authorization vote.
21 December 2025
···
Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

The FDA late Friday authorized marketing of six on! PLUS nicotine pouch products, the first such decision under a new pilot review program. Altria shares closed at $58.07, market cap $97.48 billion, ahead of a key dividend ex-date and after the company confirmed plans to resume retail and online sales for the approved pouches. The authorization covers three flavors in two strengths, with strict packaging and marketing restrictions.
21 December 2025
··
NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

Nvidia shares closed near $181 on Dec. 19, 2025, with market cap estimates around $4.4 trillion. Reports surfaced that China’s Tencent may be accessing banned Nvidia Blackwell AI chips via overseas cloud providers. U.S. officials also launched an interagency review that could allow H200 chip sales to China. Wall Street analysts described Nvidia as “cheap” by historical standards.
21 December 2025
·
Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber Stock (NYSE: UBER) News, Forecasts and Analysis on Dec. 20, 2025: Robotaxi Fears, FTC Lawsuit Headlines, and Wall Street’s Next Targets

Uber closed at $79.31 on Dec. 19, 2025, down about 20% from its fall peak but up for the year. The company faces renewed regulatory pressure after the FTC and 21 states filed an amended lawsuit over Uber One practices, sending shares down over 3%. Investors remain focused on legal risks and competition from robotaxis as Uber continues to post profits and expand its platform.
21 December 2025
·
Caterpillar (CAT) Stock News & Forecasts: Analyst Price Targets, Dividend Update, and 2026 Outlook as of Dec. 20, 2025

Caterpillar (CAT) Stock News & Forecasts: Analyst Price Targets, Dividend Update, and 2026 Outlook as of Dec. 20, 2025

Caterpillar shares closed at $576.22 on Dec. 19, up 1.84% after a volatile week that saw the stock drop from a Dec. 12 close of $597.89. Financial Enhancement Group sharply increased its CAT holdings in Q3, while Jackson Square Capital reduced its position, according to new filings. Insiders sold 79,061 shares worth about $41.95 million last quarter.
21 December 2025
·
CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike Stock (CRWD) News, Forecasts and Analyst Outlook: What’s Driving Shares as of Dec. 20, 2025

CrowdStrike shares closed at $481.28 on Dec. 19, 2025, after trading as high as $489.20, with volume near 4.64 million shares. The stock’s movement follows strong Q3 FY2026 results: revenue rose 22% to $1.234 billion, and the company raised full-year guidance. Wall Street focus remains on annual recurring revenue and the pace of new customer growth amid ongoing AI-driven product expansion.
21 December 2025
·
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

AbbVie shares closed at $226.82 on Friday, up 1.8%, nearing a 52-week high with a market cap near $400 billion. U.S. drug pricing policy returned to focus after the Trump administration announced agreements with nine drugmakers, excluding AbbVie, which remains in upcoming negotiations. New Medicare pilot programs tied to international price referencing were also announced. Trading volume approached 19 million shares.
21 December 2025
··
1 … 524 525 526 527 528 … 693
Go toTop